AGWCA
TMDX icon

Annis Gardner Whiting Capital Advisors’s Transmedics TMDX Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Buy
2,637
+1
+0% +$130 0.04% 275
2025
Q4 		$321K Buy
2,636
+1,090
+71% +$137K 0.06% 237
2025
Q3 		$173K Buy
1,546
+1,516
+5,053% +$177K 0.04% 285
2025
Q2 		$4.02K Buy
+30
New +$3.29K ﹤0.01% 885

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's TMDX Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors increased its Transmedics (TMDX) stake by 0.04% in Q1 2026, buying an estimated $130 and bringing the position to 2,637 shares worth $262K. The position accounts for 0.04% of the portfolio, ranked #275.

Annis Gardner Whiting Capital Advisors first reported a position in TMDX in Q2 2025 and has held it in 4 quarters since. The position peaked at $321K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors held 2,637 shares of Transmedics worth $262K as of Q1 2026.
  • Annis Gardner Whiting Capital Advisors bought 1 Transmedics share in Q1 2026, an estimated $130.
  • Transmedics made up 0.04% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #275 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Transmedics in Q2 2025 and has held it in 4 quarters since.
  • Annis Gardner Whiting Capital Advisors's Transmedics position peaked at $321K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.